safety of risankizumab in patients with psoriasis and hepatitis B and C
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients
Paolo Gisondi;Miriam Pizzolato;
2023-01-01
Abstract
safety of risankizumab in patients with psoriasis and hepatitis B and C
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
